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Skin irritant reactions are under the control of a 
network of cytokines and lipid Inediators. This study 
characterized the production of tUInor necrosis fac-
tor-a (TNF) induced by a skin irritant treatInent, 
tributyltin (TBT), in wce through transcription fac-
tor activation and its pharInacologic Inodulation by 
anti-inflaInInatory agents. Tbe ears of BALB/c Inice 
were painted with different aInounts of TBT (67-536 
nInol in acetone) or with acetone alone. At different 
times thereafter, TNF production was analyzed both 
at the InRNA and protein level, by semiquantitative 
RT-PCR and L929 cytotoxicity assay, respectively. 
TBT induced rapid (1 h) TNF gene expression and 
protein synthesis. MaxiInal TNF production was ob-
served 2 h after treatment. The production of TNF 
was paralleled by accuInulation of skin water; this 
was partially prevented by intraperitoneal injection 
Skin irritation involves resident epidermal ce lls, fibro-blasts of dermis , and endotheljal ce lls as well as invading leukocytes interacting under the control of a network of cytokincs and lipid mediators (Boss and Kapsenberg, 1993). Because of their anatom ical location, a rol e for 
cytokines produced by keratinocytes, especially inte rleukin-la 
(IL-1 a), has been proposed (Kupper, 1990). T he hypothes is is that 
every time the ep idermis is damaged, active IL-1 a is re leased as a 
primary event in skin defense (Nickoloff ef ai , 1990). IL-la release 
stimu lates further produ ction of IL-l a together with synthesis of 
other cytokines such as lL-6, lL-8, and inte rcellular adh esion 
molecules, thus amplifying the response (Kupper, 1989) . 
W e used tributyl tin (TBT) as an agent to incite the skin irritant 
reaction . Indeed, occupationa l and accidental exposure to TBT, a 
biocidal agent used mainly in wood preserva tion and marine 
antifouling paints, can result in skin and eye irritation, and severe 
dennatitis has been reported after direct contact with the skin 
(reviewed by World Health Organization, 1990) . W e have previ-
ously demon strated (Corsini ef ai, 1996a) the involvement of IL-1 a 
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of antibody against murine TNF. These data indicate 
that skin irritation induced by TBT is attributable, in 
addition to the actions of other inflaInInatory Inedi-
ators, to the action of keratinocyte-derived TNF. 
TNF production was preceded by a rapid (5 min) 
activation of nuclear factor-KB (NF-KB), which was 
also maximal 30 min after treatInent. TBT-induced 
accumulation of skin water and TNF production were 
significantly reduced by topical treatment with dexa-
methasone and pentamidine, two anti-inflammatory 
agents. Interestingly, dexamethasone, but not pent-
aInidine, decreased TBT -induced NF-KB activation, 
confirIning in vivo that the glucocorticoid receptor 
interacts functionally within the nucleus with other 
transcription factors opposing one another's activity. 
Key words: orgallotill/NF-KBlskill iJ'Yitatioll. ] ["vest Der-
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in TBT -induced skin i.n;tation in the mouse. The prior injection of 
anti-murine lL-1 a aJltibody, however, red uced skin irritation by 
only 50'X,. The analysis of the expression of cytokine mRNAs by 
reverse transcriptase-polymerase chain reaction (RT -PCR) showed 
that T BT treatment is also able to induce other cytokines such as 
IL-6 and tumor necrosis factor (TNF) , which supports the hypoth-
esis of con com.itant re lease of other inflammatory mediators after 
TBT treatment; inte res tingly, prior treatment with TL-l a antibody 
partially inhibited (45%) the TBT-induced express ion of IL-6 but 
not that of TNF, which may partially account fo r the antibody 
protection observed. 
[n the skin, TNF is stored in dermal mast cells (Gordon and Galli , 
1990), but followin g stimulation it may be produced by keratino-
cytes (Kock e{ ai, 1990) and Langerhans ceUs (Larrick c{ ai, 1989). 
An increasing body of evidence suggests that TNF is fun ctionally 
relevant to a variety of inflammatory skin diseases, both in rodents 
and humans (Wakefi e ld et ai, 1991; Groves cl ai, 1995) . Antibody to 
TNF abolishes many inflammatory skin reac tions , including allergic 
and irritant contact dennatitis (Piguet c { ai, 1991) and graft- lIcrsl/s-
host disease (Piguet e{ ai, 1987). An important mechanism by which 
TN F influen ces the de velopment of an inflammatory reaction i 
indu ction of the express ion of cutaneous and endothelial adhesion 
molecules (Fober and Co.mran, 1990; Groves cf ai, 1995). Inducible 
expression of cytokines is controlled by regulation of the activ ity of 
transcription fa ctors (Muegge and Durum, 1990). In particular, 
nuclear factor-KB (NF-I<B) (Shako v e{ ai, 1990) and activator 
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protein-lIc-jllll (Rhoades et (/1, 1992) have bee n implicated in TNF 
expression. We have pre viously d e monstrated (Corsini ef nl, 1996b) 
that TET is able to induce a con centration-dep endent NF-KB 
activation in a murine keratinocyte cell line. 
The purpose oftl-us study was to furtb e r investigate in m o use skin 
the role of cytokines, il] partic ular TNF, in skin irritation through 
the ability ofTBT to induce ill Ilifl i! NF-KB activation. We focused 
our a ttention on this transcription filctor because NP-KE is a 
primary transcription factor, and its activation occurs without n ew 
protein synthesis (Eae uerle and Henke l, 1994). Finally , w e modu-
lated TET-induced skin irrita tion using d examethasone and pent-
amidine. Corticostero ids are the most effective therapy currently 
available for the treatment of many skin diseases, whereas pentam-
idine is an aromatic diamidine currently used to treat Pll el/l/loC)'stis 
carinii pneumonia in acquired immunode fi c ie n cy syndrome patients 
(Sands et (/1, 1985), for which w e have previously demonstrated 
an ti-inflammatory properties in diff'erent systems, including the skin 
(Blay loc k cl: (/1, 1991; Corsini cf nl, 1992, Rosenthal ct ai , 1992). 
MATEIUALS AND METHODS 
CbelDicals Tributyltin chloride was obtained fi'om Aldrich (Steinhcin, 
Germany) , dexamethasone £i'om Sigma (St Louis, MO), and pentamidine 
isoduonate £i'om Lyphol11ed (Melrose Park, IL). All reagents were pur-
chased at the highest purity available. 
Anin2als Nine CO 12-wk-old fema le BALB/c mice (Charles River. Calco, 
Italy) were used throughout these studies. Mice wcre randomized inm 
trea tment groups, housed three CO fo ur per cage over woodchip bedding , 
and all owed food and water ad libi/lIl11 . Before creatment mice were 
quarantined for 2 wk and were acclimati zed co a 12-h light-dark cycle. 
Anin2al Exposure Groups of three 0 0: [our mice received d ill'erent 
amounts (67-536 I1mol) ofTBT disso lved in 10 /-LI of acetone on both sides 
of one ear or an equal volume of acetone alone on tbe other car (Dla )'lock 
(I aI, 1991). T he concentrations were chosen from a previous study 
(Middleton and Pratt, 1977) . Ears were treated on both sides to maximize 
indn ction of cytokine production . At various times after treatment. mice 
were killed . and the cars were removed. Half of each ear was nsed to 
dctenninc the \va ter content frOlU the corresponding wet and dry weights, 
the latter measured after heating at 105DC for 24 h . The other half was 
wash e d once in phosphatc- b\1lfcred saline and sliced (R.osenthal el 01, \ 992), 
and the slices were incubated overnight in 1 1111 of RJ'M[ '1640 (Sigma) 
containing 2 mM L-glueamine, 0.1 11Ig streptomycin per 1111 , 100 IU 
penicilun P CI' ml , and 10% feta l bovine serum (Sigma) (medium). IL-1 C1' and 
TNF released iJl to the medium wCre dctermiJ1ed by enz)'me-linkcd il11l11u-
nosoibent assay (ELISA) and the L929 cytotoxicity assaI', respectively. T he 
TN F content of wbole ears was determined in skin homogenate prepared as 
fo llows. Ears were minced with sca lpels and homogenized in 1 ml of 
medium with a ti.ssuc homogenizer (Camlab, Cambridge, U.K.) for 20 s. 
The samples were then frcezed-thawed twice , sonica ted for 15 s, and fina\J)' 
centrifuged for 5 min ,It 15000 rpm. Supernatants were stored at - SODC. 
In a n anoeher experiment. ,mimaIs (n = 4) were injected intraperitonea\Jy 
with 200 ILl of poll' clonal anti-mouse TNF antibody (Gcnzymc, Cambridge, 
MA) or with rabb it pre-immune serum 'I h and 30 min before TnT (268 
runol) Or acetone treatnlent. Animals werc killed 2 h later. and skin water 
conte n t Was assessed as previously described. 
For the pharmacologic modulation ofTBT-induced skin irritation, mice 
wcre painted w ith 268 nnwl of TBT or acetone and then with dexameth-
asone (30 ILg in 10 /-LI of acetone) or pentamidine (80 ILg in 10 I·d of 
acetone). The doses of pentamidine and dexamethasone we re chosen from 
previo u s studies (Blaylock et nf, 1991) . Pentamidine was disso lved in 
distilled water at a concentration of 1 % and then diluted in acetone for 
topical app lication. Dexamethasone was disso lved directly in aceeone. Mice 
were !ciUcd 30 min or 2 h l:ltcr fo r the preparation of nuclea r extract or 
dete rmination of skin water and TNF content, respecti vely. 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
RT -peR reactions were performed as previously described (Corsini ef of. 
1996a). Commercially availab le PC R primers for TNF- c< and glyceralde-
h)'de 3-phosplJ<1te dehydrogenase (GPDI-I) were purchased /i'om Clontech 
laboratories, Inc. (Palo Alto. CA) and contained the fo llowing sequences: 
mouse TNF-c<: sense, S' -ATGAGCACAGAAAGCATGACCGC-3' 
antisellse, 5' -CCAAAGTAGACCTGCCCGGACTC-3' 
mouse GPDH: sense. 5'-TGAAGGTCGGAGTCAACGGATTT-3' 
antisense, 5' -C A TGTGGGCCA TGAGGTCCACCAC-3' 
T h e amplified PC R. products from cytokine RNA arc 692 bp for TNF-c< 
and 983 bp for GPDH . ll1 preliminary experiments, RNA concentrations 
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and PC R cycles were titrated to establish standard curves to document 
lincarity ~l11d eo permit semiquantitative an"lysis of sign al strength . Gels 
were photographed with type S5 positive-negative fi lm (Po laroid , Cam-
bridge, MA). 
Preparation of Nuclear Extracts and Electrophoretic Mobility Shift 
Assay (EMSA) Nuclear extracts werc extracted fro111 minced ear skin that 
had been washed with phosphate-bulfercd saline 'md homogenized in 2 1111 
of a hypotonic lySis bu/fer (bu/fer A: '10 lllM HEi'ES, pH 7.8, 10 mM KC1, 
2 mM MgCI" 1 mM dithiothre itol, 0.1 mM ethylenediaminecctraacetic 
acid , 0.1 111M phcl1 ),lmechylsulfon)'1 flu oride) wieh a tissue homogenizer for 
20 s. Homogenates were kept Oll icc for 15 min , 12S ILl of a 10% Nonidet 
P-40 solution was added and mixed for 15 s, and the mixture WaS chen 
centrifuged for 30 s at 12,000 rpm. T he pe lleted nuclei were washed once 
with 400 /-L1 of butfer A plus 25 fLl of] 0% NP-40, centrifuged, alld then 
suspended in 50 /-LI ofbntfer C (50 mM HEPES. pH 7.8, 50 mM KCI, 300 
mM NaCl, 0.1 111M ethylenediaminetetraacetic acid . 1 mM dithiothTeitol. 
O.lmM phenylmctl1ylsulfonyl fluoride, 10'}\, (vollvol) glycerol). mixed for 
20 min , and centrifuged for 5 min at 12 ,000 rpm . T he supem atant 
containing nuclear proteins \vas h.u:vcsted . protein concentratio n \~' as 
determined , and the supematant was stored at -80DC nntil used in EMSA . 
EMSA was performed as follows. Binding reaccion mix cnres (20 iL l ) 
containing 5 J.l.g protein of nuclea r extract. 0.5 iLl,' poly(d l-dC) . poly(dl-dC) 
(Sigma). 10,000 cpm 32P_Iabeled probe ill binding buller (10 mM HEPES, 
pH 7 .9, 50 rnM NaCI, l rI1M cthylenediamine tetraacetic acid, 1. mM 
dithiothreicol, 10% (vol/vo l) glycerol , 1 % Ficoll and 0.2 J.l.g per mJ albumin) 
\\fere incubated for 30 111jn ilt rOO I11 tClllpcrature before separation in a 7%1 
acrylamide gel in 1 X Tris-boratc-ethylcncdiamiuetetraacetic acid fo llowed 
by autoradiography. A double- so'andcd o ligonucleotide cont'lining the 
bUlding site for NF-KB (S ' -GTCTCGCAATTCCCCT CTCT CAG-3 ') was 
l"bcled with [a-"PJdA TP (Amersham, Buckinghamshirc, U.K.) using T4 
polynucleotide kinase (Amersh"m). 
Assay for TNF TNF content w"s assayed by determining the cyt,oto"iciry 
ofTNF against sensitive L929 cells as previonsly described (Rosenthal and 
Corsini . 1995). R abbit anti-murine TNF (Gcnzyme) polyclonal antibody 
was llsed to demonstrate that the cytolytic activity Was due to the presence 
of TNF in the conditioned media (dara not shown) . T he results arc 
expressed in picogra111s/mg dry tissue o r picogra1l1s/ear for rel ease and total 
TNF content, respectively. TNF concentration was ca lcnlated against a 
standard curve with known amo ul1CS of recombinan t murine TN F (Gcn-
zyme). 
Enzyme Linked Immunosorbent Assay (ELISA) IL-1 C1' content was 
measured by a specific sandwich ELISA as previously described (Corsini c/ 
ai, 1996,,) . T he limie of sensitivity for this assay is 15 pg/mL Results are 
expressed Ul pg/mg dr)' tissue. Preliminary studies showed that the maxi-
mnm TET concentratiolls tested did no t interfere with d,e ELI SA. 
Statistical Analysis All expm;menrs w ere performed aC least twice; 
representati ve results arc shown . Statistical significance was determined by 
Student's t test or Dunnett's multip le comparison test as indica ted. after 
arwlys is of variance. 
RESULTS 
TBT Induces TNF Production Figure 1 shows dle RT-PCR 
analysis of TNF gen e expre ssion after exposure for different times 
and con centrati.ons ofTBT. In the control animaJs, the low level of 
constitutive expression ofTNF may b e associate d with tb e presen ce 
of dermal mast cells, w hich store previously form ed TNF (Gordo n 
and Galli , 1990) . Afte r treatment w ith TBT, a rapid and dose-
re lated upregulation ofTNF mRNA was o bserved , detectable after 
1 h of treatment and re maining e levated up to 4 h. Maximal TNF 
production was detected 2 h after trea tment (Fig 2); b y 24 h th e 
levels ofTNF w e re b ack to control v alues. As sh own in Fig 2 , the 
kinetic of TBT-induced IL-l a production p ara lle ls TNF release , 
w l-uch supports the idea that other inflammatory m ediators are 
re leased after TBT treatment. After 2 h TBT induced a dose-re lated 
produc tio n ofTNF, along with accumulation of skin wate r (Table 
I) . \.ntrape ritoneal injection of a TNF-neutralizing antibo d y par-
tiall y prevented TBT-indu ced accumulation of skin water (Fig 3), 
which indica tes that skin irritation induced b y TBT is in part 
attribu table to the action of keratinocyte-derived TNF. 
l.nducible expression of TNF is controlled b y regulation of the 
activity of transcription factors N F-KB (Shakov CI (/1, 1990). Indeed, 
as shown in Figure 4, TBT-induced T NF produ c tion was preced ed 
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(a) Table I. Skin Irritant Induces a Dose-Related Effect on 
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Figure 1. Skin irritant induces TNF gene expression. T ime course 
and dose response of TNF gene express ion induced by TBT: RT-PCR 
ana lysis. (a) Photograph of TNF a.nd GPDH amplification products from 
murine skin 1-4 h "fter topical application of268 nmol ofTBT or "cetone; 
(b) the same products 2 h after different doses of TBT or acetone (0-536 
omol). C. acetOlle vehicle cOll trol; T . TBT-treated allimals; (+ ). PCR-
positive contro l; (- ). no RNA. 
;11 II;IJO by a rapid (5 min) N F-KB activation , w hich was max imal 30 
min aftcr treatment. 
Anti-inflammatory Agents Modulatc TBT -Induced Skin 
Irritation W c thcn investigated whether TBT -induccd skin 
irritation is modu lated by dexamethasonc and pentamidine, two 
anti-inflammatory agen ts. Corticosteroids are the most effective 
therapy currently ava ilable for the treatment of many skin diseases, 
although we have previously demonstrated thc an ti-inflammatory 
properties of pentamidine in different system s, incl uding the skin 
(Blaylock ct ai , 1991; Corsini cl ai , 1992, Rosenthal el ai, 1992). 
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Figure 2. IL-la and TNF show parallel release following skin 
irritant reac tion. T ime course ofTBT -induced release off L-l a and TNF 
fro m ear skin slices at different times after topical application of268 IImol of 
TBT. T ime 0 shows basa l release of IL-l a and T NF from control animals; 
the release remained constant throughout the times ana lyzed and was not 
affected by application of vehicle. Eacb va lue represents the mean ::: Sf) of 
th ree determinations. Statistical analysis by Student's t test; " p < 0.05 for 
IL-l a release l/CJ'SIiS control; S, p < 0.05 for T NF release "ers lIs control. 
TNF-a Production and Accumulation of Skin Water" 
TBT T NF-a TNF-a Total Skin Water 
App lied R.elease Content Content 
(ll111ol / side) (pg/mg d.w .) (pg/ear) (mg H20 / mg d.w.) 
0 0.4 ± 0.1 8.9 ± 2.5 0.84 ± 0.06 
134 2.7 ::: 0.5" n.d. 1.51 ::: 0.04" 
268 7.3 ± 0.3" 103 ± 45.6" '1.58 ± 0.24" 
536 8.5 ± 1.2" 281 ::: 133" 1.67 ::: 0.08b 
,/ Groups of three mi ce were treated with diJrcrcnt concentrations ofTBT or acetone 
vehicle a ll both side of each ear. Anim:l ls were terminated 2 h late r. and TNF-Q: 
re lease, total TNF-a . :md skill water content of the cars were measured . Each value 
represellt.s the I11C<lll ± SO of three determinations. 
/. SI":1ristic:lI analysis by D unnett's [cst: • . p < 0.0 1 I't.TSI/S co n trol (treatment 0) ; n.d., 
not done; d.w .• dry weigh t. 
signifi cantly both TBT-induced T NF produ ction and skin water 
accumulation, which confirm s that the ir anti-inflammatory capacity 
is associated with a modulation of cytokine production . In Fig 5 
w e showed that dexam ethason e is able to prevent TBT-inducec! 
N F- /(B activation ; 11 11;110, confirming that inhibi tion of transactiva, 
tion ma y be an important m olecular m echanism for dexam ethasone 
anti-inA am mato ry action, although this is not th e mechanism fo t 
pentamid ine. 
DlSCUSS ION 
T he purpose of this study was to charactel;ze in mice the produc, 
t ion ofTNF and the activa tion oftransct;ption factor NF-KB during 
an irritant reaction, using TBT to incitc the reaction , and theiJ: 
m o dulation by anti-inflammatory drugs. W e chose TBT because it 
is a biocide that has been extensi ve ly used in the past, and its irritant 
e ffect is w e ll documented in both human and roden ts (Worle! 
H ea lth Organ iza tion , 1990). As an ;11 ";110 model we chose the eat 
swcll.ing test. We have previously es tahlished (Corsini cf ai , 1996a) 
that TBT applied to mouse ears induccs an irri tant reaction wid, 
maximum levels w ithin 4 h, a peak time similar to that found by 
Middle ton and Pratt (1977) for TBT and rat dorsal skin. A s 
previo usly m entioned , we have also dcmonstrated a direct role Of 
IL-1 a in the ;11 11 ;110 effect of TBT. Prior treatment with a neutral, 
izing antibody against IL- 1a reduced skin irritation by only 50%, 
however, w hich indica tes the involvcm ent of o ther TBT-induced 
inflammatory mediators such as arachidonic acid metabolites Or 
other cytokines. In particular , as indicatcd by R T -PC R analysis, 
T NF expressio n was not affected by prior treatment with IL-1 Q 
antibody . lndeed, he re we dcmonstra te that the kinetics of TNt: 
Figure 3. Protective effect ofanti-TNF antibody in skin irritation. 
Protection by injected antibody to murinc TNF against TI3T-induced 
increase in skin water content 2 h afte r treatment. Each va lue represents the 
mcan ::: SD of three to fO ll r dercn11 inations . Statistical ana lysis by Student' 
t test; . , p < 0.05 "e/'s IiS vehicle control; S, p < 0.05 l"/'SIIS animals treated 
with TBT and normal rabbit seru m. 
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Figu.re 4. Skin irritant rapidly induces NF-KB activation jll "j"o. 
Time COurse of TBT -induced N F-KB activation aftcr topical application of 
268 1unol ofTBT or acetone vehicle control (0 min) and the effect ofNF-KB 
competition when a 100-fold excess of cold probe was used to demonstrate 
NF-KB complex specificity (cold). Equal amounts (5 JLg) of nuclear extracts 
were analyzed by EMSA. with a UP_labeled DNA probe detecting the 
binding activity of NF-KB. 
and of lL-1a release from ear slices after trea tment with TBT 
occurred in parallel , which confIrms that TNF production induced 
by TBT is independent of IL-1 a release and clearly indicates that 
IL--l a is not necessarily the primary event in the skin defence 
mechanism but only one of the inflammatory mediators involved. 
Recombinant TNF has marked pro-inflammatory effects in nor-
mal skin and is capable of recruiting a variety ofinflammatory cells, 
modulating adhesion expression, and inducing changes suggestive 
of L3J.lgerhans cell mi gration (Groves c( ai , 1995). It has been 
previously reported that keratinocyte-derived TNF mRNA is rap-
idly upregulated following treatment with irritants and allergens in 
mice (Enk and Katz, 1992). Also in our experien ce, skin irritants, 
such as sodium dodecyl sulfate, or skin allergens, such as dinitro-
chlorobenzene and oxazolone, all induce TNF production (data 
not shown). Here, we show that TBT also induces a rapid and 
dose-dependent TNF production , which was l11<ua.mal 2 h after 
treatrrlent. Skin water accumulation following TBT treatment 
could be modulated by systemic treatment of mice with a neutra l-
Table II. Pentamidine and Dexamethasone Modulate 
Skin Irritant-Induced TNF-a Production and Skin Water 
Accumulation" 
T rcatnl cnt 
Acetone 
TaT 268 nnlOl 
Pentatnidine 80 fLg 
PentaITIidine + TBT 
Dex3Jnethasone 30 JLg 
Dexamethasone + TBT 
TNF-a: Total Content 
(pg/ea.r) 
1.9 ::':: 0.6 
11 8.6 ::':: 34.2" 
2.9 ::':: 1.0 
65.7 ::':: 9.6" " 
2.6 ::':: 0.4 
17.9 ::':: 6.3.1· ,. 
Skin W ater Content 
(mg H 20/mg d.w.) 
1.27 ::':: 0.05 
1.94 ::':: 0.13" 
1.13 ::':: 0.05 
1.44 ::':: 0.01"' " 
1.07 :': 0.03 
1.35 :': 0.09'" 
Il Groups of fOllf mi ce were painted 011 both cars with acemne or an anti -
inRam nlatory in th e pn.~$cncc or absell ce of TBT. An illlaJs werc killed 2 h late r. Each 
valu e represents the m ean ::!: SO of follr dctcnnin<ltions. Stati st ical analysis by SCUdCllt' s 
t tcst. 'with as follows: 
b p < 0.0 I " S relati ve cOl1trol. 
' p < 0.05. 
,I P < 0.05 lIS TBT -treated :l1IimaLs. 
• p < 0.05. 
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+ pentamidine + dexamelhasone 
I 
o 268 o 268 o 268 TBT nmoUside 
NF-KB 
free probe 
Figure 5. Dexamethasone modulates NF-KB activation j" v jl'o . 
Modulation of TBT -induced NF-KB activation after 30 min of treatment 
with acetone (0) or 268 11111 0 1 of TBT in the presence or absence of 
pentamidine or dexamethasone ( + ). Equal amounts (5 fLg) of nuclear 
extracts were analyzed by EMSA, with a 32P-labeled DNA probe detecting 
d,e binding activity of NF-KB. 
izing antibody to T NF, so this cytokine must play an important role 
in irritant reactions and, in particular, in TBT-induced skin irri ta -
tion . 
The activation of transcliption factor NF-KB is involved in TNF 
expression (Shakov c( ai, 1990). In this study, we investigated th e 
ability of TBT to induce N F-KB activation i/l lIivo. In the resting 
cell, NF-KB resides in the cytoplasm as a latent form compl exed to 
the inhibitory proteii, IKB (Baeuerle and H enkel, 1994). Upon cell 
stimulation, NF-KB is rapidly activated by its release from I KB , and 
this allows it to migrate into the nucleus and subsequently bind to 
DNA. NF-KB controls the inducible ex-pression of various gen es 
that are involved in immune responses and inflammatory and 
cellular defense m echanisms. We have previously shown (Corsini c( 
ai, 1996b) that TBT induces a con centration-dependent NF-I<B 
activation in a murine keratinocyte cell line (HEL30). Here. we 
report tl,a t TBT induces a rap id (5 min) activation ofNF- KB ill. uil/o. 
An early toxic action of TBT in rat skin is to inhibit oxidative 
m etabolic pathways (Mjddleton, 1982); trio rganotins, in general. 
bind to a component of th e ATP synth ase complex , disturb the 
pro ton gradient, and inhibit mitochondrial ATP synthesis (Snoeij e ( 
ai, 1987; Marinovich el ai , 1990). We speculated th at TBT is also 
likely to cause disturbances ill vi l)o in the respiratory chain in 
mitochondria , with the productio n of reactive oxygen inte rmedi-
ates that activate transcription factors and promote th e synthesis of 
TNF and other pro-inflammatory molecules, as already demon-
strated ill I) i(/'O (Corsini c/ ai, 1996b) . 
Finally, we investigated the possibility of moderatin g TBT-
induced skin initation by th e use of dexamethasone and p entami-
dine . D exam etllasone and pentamidine both reduced TBT-induced 
skin water accumulation and TNF produ ction . Regarding the 
m echanism of action, recent reports have indicated that stimulation 
of glucocorticoid receptors antagonizes the action of many inflam-
matory m ediators ' second m essenger systems tha t all con verge on 
th e activation of transcription factors (Schule c/ ai, 1990; Adcock el 
ai, 1994). T hese i/l vil l'O data indicilte that members of distinct 
classes of transcription f.'1ctors can oppose o ne anoth er 's ac tivity 
through a mech anism likely to involve protein-protein interactions. 
Indeed , we demonstrated i ll villo that inhibition of transactivation 
may be an important molecular m echanism of dexamethasone 
action but not that of pentamidine. It is not surprising that 
pentamidine did not interfere with NF-KB ac tivation because 
pentamidin e is a specific and efFective inhibito r of the release of 
cellular IL-l and TNF release fro m m acroph ages i" IIi/ro , acting 
throughout a post-translational mechanism (Rosenthal el nl, 1991 ; 
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Corsini ef ai , 1992) and conseq uently is an effective blocker of the 
murine response to endotoxin (Rosenthal ci nl, 1992). In addition, 
pentamidine exhibi ted less broad immunosuppressive action than 
dexamethasone. 
Our data support the direct induction ofTNF production ;11 11;110 
by irritant, independently of lL-l ex release, and th e involvement of 
TNF in skin irritation, which could be modulated by anti- inflam-
matory drugs. Fina lly, we confi rmed ;11 11;110 that inhibition of 
transactivation may be an important molecular mechanism for the 
action of dexamethasone. 
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